Review articlePublished 26 May 2016
Promise of new translational safety biomarkers in drug development and some challenges to regulatory qualification
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
One promise of new translational safety biomarkers (TSBs) is their ability to demonstrate that toxicities in animal studies are monitorable at an early stage, such that human relevance of potential adverse effects of drugs can be safely and definitively evaluated in clinical trials.
Subjects
Neuroscience & NeurologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Try:
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalNeuropsychiatry
- SubjectNeuroscience & Neurology
- BylineArticles whose byline prints “Frank D Sistare”
- BylineArticles whose byline prints “Joseph J DeGeorge”